Last reviewed · How we verify

Etadrol (FLUPREDNISOLONE)

Pfizer · FDA-approved approved Small molecule Quality 14/100

Etadrol (generic name: FLUPREDNISOLONE) is a fluprednisolone Small molecule drug developed by Pfizer. It is currently FDA-approved (first approved 1982).

Etadrol (fluprednisolone) is a synthetic glucocorticoid medication originally developed by Pharmacia and Upjohn. It works by binding to the glucocorticoid receptor, mimicking the effects of cortisol in the body. Etadrol is used to treat various inflammatory conditions, but its exact indications are not specified. As an off-patent medication, Etadrol is no longer protected by patents, allowing generic manufacturers to produce it. Despite this, there are currently no generic manufacturers listed.

At a glance

Generic nameFLUPREDNISOLONE
SponsorPfizer
Drug classfluprednisolone
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology
PhaseFDA-approved
First approval1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Etadrol

What is Etadrol?

Etadrol (FLUPREDNISOLONE) is a fluprednisolone drug developed by Pfizer.

Who makes Etadrol?

Etadrol is developed and marketed by Pfizer (see full Pfizer pipeline at /company/pfizer).

What is the generic name of Etadrol?

FLUPREDNISOLONE is the generic (nonproprietary) name of Etadrol.

What drug class is Etadrol in?

Etadrol belongs to the fluprednisolone class. See all fluprednisolone drugs at /class/fluprednisolone.

When was Etadrol approved?

Etadrol was first approved on 1982.

What development phase is Etadrol in?

Etadrol is FDA-approved (marketed).

What does Etadrol target?

Etadrol targets Glucocorticoid receptor and is a fluprednisolone.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing